Search

Joseph A Kaufman

Examiner (ID: 10129)

Most Active Art Unit
3754
Art Unit(s)
3752, 3993, 3727, 3754, 3108, 3104
Total Applications
1964
Issued Applications
1543
Pending Applications
181
Abandoned Applications
196

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7143945 [patent_doc_number] => 20050118649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Method of analyzing organelle-localized protein and materials for analysis' [patent_app_type] => utility [patent_app_number] => 10/501947 [patent_app_country] => US [patent_app_date] => 2003-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7547 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20050118649.pdf [firstpage_image] =>[orig_patent_app_number] => 10501947 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/501947
Method of analyzing organelle-localized protein and materials for analysis Aug 31, 2003 Abandoned
10/276014 Anti-angiogenic polypeptides Aug 25, 2003 Abandoned
Array ( [id] => 7345617 [patent_doc_number] => 20040247620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Transformation system based on the integrase gene and attachment site for Myxococcus xanthus bacteriophage Mx9' [patent_app_type] => new [patent_app_number] => 10/645818 [patent_app_country] => US [patent_app_date] => 2003-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8152 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20040247620.pdf [firstpage_image] =>[orig_patent_app_number] => 10645818 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/645818
Transformation system based on the integrase gene and attachment site for Myxococcus xanthus bacteriophage Mx9 Aug 19, 2003 Abandoned
Array ( [id] => 7136698 [patent_doc_number] => 20040044193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'C. albicans tec1 gene (catec1) and the coded tecip protein' [patent_app_type] => new [patent_app_number] => 10/380334 [patent_app_country] => US [patent_app_date] => 2003-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17694 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20040044193.pdf [firstpage_image] =>[orig_patent_app_number] => 10380334 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/380334
C. albicans tec1 gene (catec1) and the coded tecip protein Aug 18, 2003 Abandoned
Array ( [id] => 7463731 [patent_doc_number] => 20040053292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Proteins and dna sequences underlying these proteins used for treating inflammations' [patent_app_type] => new [patent_app_number] => 10/416935 [patent_app_country] => US [patent_app_date] => 2003-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 18115 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053292.pdf [firstpage_image] =>[orig_patent_app_number] => 10416935 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/416935
Proteins and dna sequences underlying these proteins used for treating inflammations Aug 14, 2003 Abandoned
Array ( [id] => 7134966 [patent_doc_number] => 20040043488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Adeno-associated viral gene-transfer vector system' [patent_app_type] => new [patent_app_number] => 10/638510 [patent_app_country] => US [patent_app_date] => 2003-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6242 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043488.pdf [firstpage_image] =>[orig_patent_app_number] => 10638510 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/638510
Adeno-associated viral gene-transfer vector system Aug 10, 2003 Abandoned
Array ( [id] => 7234211 [patent_doc_number] => 20040157287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Regulatory elements suitable for use in gene expression' [patent_app_type] => new [patent_app_number] => 10/468250 [patent_app_country] => US [patent_app_date] => 2003-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 17792 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157287.pdf [firstpage_image] =>[orig_patent_app_number] => 10468250 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/468250
Regulatory elements suitable for use in gene expression Aug 10, 2003 Abandoned
Array ( [id] => 7252372 [patent_doc_number] => 20050074843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity' [patent_app_type] => utility [patent_app_number] => 10/633699 [patent_app_country] => US [patent_app_date] => 2003-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17808 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20050074843.pdf [firstpage_image] =>[orig_patent_app_number] => 10633699 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/633699
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity Aug 4, 2003 Abandoned
Array ( [id] => 7677754 [patent_doc_number] => 20040152072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Reverse transcription' [patent_app_type] => new [patent_app_number] => 10/629859 [patent_app_country] => US [patent_app_date] => 2003-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21534 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152072.pdf [firstpage_image] =>[orig_patent_app_number] => 10629859 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/629859
Reverse transcription Jul 29, 2003 Abandoned
Array ( [id] => 7287157 [patent_doc_number] => 20040147025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof' [patent_app_type] => new [patent_app_number] => 10/624317 [patent_app_country] => US [patent_app_date] => 2003-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13563 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147025.pdf [firstpage_image] =>[orig_patent_app_number] => 10624317 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/624317
Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof Jul 21, 2003 Abandoned
Array ( [id] => 7359495 [patent_doc_number] => 20040014220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current' [patent_app_type] => new [patent_app_number] => 10/312244 [patent_app_country] => US [patent_app_date] => 2003-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5545 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014220.pdf [firstpage_image] =>[orig_patent_app_number] => 10312244 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/312244
Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current Jul 17, 2003 Abandoned
Array ( [id] => 6911831 [patent_doc_number] => 20050175589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Anti-neoplastic viral agents' [patent_app_type] => utility [patent_app_number] => 10/612285 [patent_app_country] => US [patent_app_date] => 2003-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22760 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20050175589.pdf [firstpage_image] =>[orig_patent_app_number] => 10612285 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/612285
Anti-neoplastic viral agents Jul 2, 2003 Abandoned
Array ( [id] => 281659 [patent_doc_number] => 07553658 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => 'Recovery of plasmids in an aqueous two-phase system' [patent_app_type] => utility [patent_app_number] => 10/526089 [patent_app_country] => US [patent_app_date] => 2003-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8118 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553658.pdf [firstpage_image] =>[orig_patent_app_number] => 10526089 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/526089
Recovery of plasmids in an aqueous two-phase system Jun 16, 2003 Issued
Array ( [id] => 7364688 [patent_doc_number] => 20040005625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Method of analyzing expression of gene' [patent_app_type] => new [patent_app_number] => 10/460784 [patent_app_country] => US [patent_app_date] => 2003-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9797 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 306 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005625.pdf [firstpage_image] =>[orig_patent_app_number] => 10460784 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/460784
Method of analyzing expression of gene Jun 11, 2003 Abandoned
Array ( [id] => 6769980 [patent_doc_number] => 20030215920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Formaldehyde dehydrogenase genes from methylotrophic yeasts' [patent_app_type] => new [patent_app_number] => 10/459970 [patent_app_country] => US [patent_app_date] => 2003-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15776 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215920.pdf [firstpage_image] =>[orig_patent_app_number] => 10459970 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/459970
Formaldehyde dehydrogenase genes from methylotrophic yeasts Jun 11, 2003 Issued
Array ( [id] => 8016807 [patent_doc_number] => 08137904 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-20 [patent_title] => 'Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue' [patent_app_type] => utility [patent_app_number] => 10/516785 [patent_app_country] => US [patent_app_date] => 2003-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5634 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/137/08137904.pdf [firstpage_image] =>[orig_patent_app_number] => 10516785 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/516785
Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue Jun 4, 2003 Issued
Array ( [id] => 7423020 [patent_doc_number] => 20040229362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Method for producing non-pathogenic helper virus-free preparations of herpes virus amplicon vectors, the helper virus & the cells used in this method, the corresponding genetic tools, as well as the applications of these non-pathogenic amplicon vectors' [patent_app_type] => new [patent_app_number] => 10/438019 [patent_app_country] => US [patent_app_date] => 2003-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13833 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229362.pdf [firstpage_image] =>[orig_patent_app_number] => 10438019 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/438019
Method for producing non-pathogenic helper virus-free preparations of herpes virus amplicon vectors, the helper virus & the cells used in this method, the corresponding genetic tools, as well as the applications of these non-pathogenic amplicon vectors May 14, 2003 Abandoned
Array ( [id] => 7219766 [patent_doc_number] => 20040072171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Method for identifying compounds for modulating the activity of a tumor suppressor protein' [patent_app_type] => new [patent_app_number] => 10/296424 [patent_app_country] => US [patent_app_date] => 2003-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8848 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072171.pdf [firstpage_image] =>[orig_patent_app_number] => 10296424 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/296424
Method for identifying compounds for modulating the activity of a tumor suppressor protein May 12, 2003 Abandoned
Array ( [id] => 7134456 [patent_doc_number] => 20040043380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'T cell line and use thereof' [patent_app_type] => new [patent_app_number] => 10/416362 [patent_app_country] => US [patent_app_date] => 2003-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10189 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043380.pdf [firstpage_image] =>[orig_patent_app_number] => 10416362 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/416362
T cell line and use thereof May 7, 2003 Abandoned
Array ( [id] => 7426721 [patent_doc_number] => 20040265805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Method for cloning large DNA' [patent_app_type] => new [patent_app_number] => 10/429295 [patent_app_country] => US [patent_app_date] => 2003-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 4276 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265805.pdf [firstpage_image] =>[orig_patent_app_number] => 10429295 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/429295
Method for cloning large DNA May 1, 2003 Abandoned
Menu